Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Capital Market

28.15USD
24 Apr 2018
Change (% chg)

$-0.20 (-0.71%)
Prev Close
$28.35
Open
$28.60
Day's High
$28.90
Day's Low
$27.65
Volume
72,979
Avg. Vol
117,641
52-wk High
$37.55
52-wk Low
$2.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.666
Sep '17 0.00 -0.655
Jun '17 0.00 -0.735
Mar '17 0.00 -0.732
FY 2016 Dec '16 0.00 -0.990
Sep '16 0.00 -0.975
Jun '16 0.00 -1.108
Mar '16 0.00 -1.131
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 2.50 10.00 0.00 37.75
Year Ending Dec-19 6 1.42 8.50 0.00 41.78
Earnings (per share)
Quarter Ending Jun-18 5 -0.68 -0.55 -0.81 -0.59
Quarter Ending Sep-18 5 -0.70 -0.57 -0.89 -0.61
Year Ending Dec-18 5 -2.70 -2.25 -3.34 -2.07
Year Ending Dec-19 7 -2.88 -1.86 -3.81 -1.78
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta 1.68 0.90 0.88
Price to Sales (TTM) -- 110.89 5.71
Price to Book (MRQ) 4.36 13.58 5.37
Price to Tangible Book (MRQ) 4.36 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 65.71 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 33.65 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 20.31 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate 12.20 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 7.86 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -- -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.75 10.96
Operating Margin (TTM) -- -718.53 4.73
Operating Margin - 5 Yr. Avg. -- -596.06 6.40
Pre-Tax Margin (TTM) -- -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.42 6.81
Net Profit Margin (TTM) -- -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,626,821 846,830,978
Net Income/Employee (TTM) -1,448,615 2,971,371 99,616,195
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.89 -1.11 10.95
Return on Assets - 5 Yr. Avg. -84.50 -0.57 12.31
Return on Investment (TTM) -91.06 1.58 14.38
Return on Investment - 5 Yr. Avg. -108.20 2.21 16.10
Return on Equity (TTM) -91.23 2.41 16.07
Return on Equity - 5 Yr. Avg. -108.28 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -10.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mirati Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.44%
# of Holders: 88
Total Shares Held: 23,927,138
3 Mo. Net Change: 1,515,379
# New Positions: 7
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 1
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.